Grail’s Cancer Detection Test Fails in Major Study

A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in ...
Forbes

Why Blood Test For Early Detection Of Alzheimer’s Disease Matters

Set to launch this month, a recently approved blood test to detect biomarkers for Alzheimer’s disease could bring diagnosis into everyday clinical practice. In turn, this may support earlier ...
Business Wire

Final Results From PATHFINDER Study of GRAIL’s Multi-Cancer Early Detection Blood Test Published in The Lancet

MENLO PARK, Calif.--(BUSINESS WIRE)--GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, today announced that detailed findings from the PATHFINDER study of ...
ascopubs.org

Multicancer Early Detection Blood Test Performance in Cancer Survivors From the PATHFINDER Study

Imaging- and Tumor Biomarker–Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer Previous cancers included ...
Monthly Prescribing Reference

FDA Clears Blood Test for Early Detection of Amyloid Pathology

Findings showed testing with Elecsys pTau181 helped to rule out Alzheimer pathology with a 97.9% negative predictive value in this early disease-stage population. The Food and Drug Administration (FDA ...